Abstract HR-MAS NMR spectroscopy was employed to monitor the metabolic profiles of Modena BioBank breast samples over 1 year of freezing at -80°C. The study includes 22 adult female patients living in Modena and its hinterland, who underwent total mastectomy or quadrantectomy in 2011-2012. Variations occur, especially affecting phosphocholine (PC) and choline. This is not a trivial finding, since many studies base the distinction between neoplastic and healthy tissues or the assessment of tumor grade on the analysis of choline metabolites. Despite the changes observed, we established that the diagnostic power of the HR-MAS NMR spectra of frozen samples is preserved, at least as far as the distinction between neoplastic and healthy samples is concerned. Lactate (Lac), PC, phosphoethanolamine (PE), taurine (Tau), myo-inositol (Myo) and glucose (Glc) are biomarkers that can be used to distinguish healthy from neoplastic tissues, whereas some metabolite ratios, such as Lac ? PE ? Tau/Glc ? Myo, seem to have even higher discrimination potential.
surgery samples dates back to 1997. It represents an actively investigated field, and it is used to obtain the metabolic fingerprints of tissues. It has been shown that HR-MAS NMR is able to differentiate between normal and neoplastic tissues in the case of breast, brain, head and neck squamous cell carcinoma, bladder, kidney, colon cancer and other malignancies in the gastrointestinal tract and to help in the characterization of metabolic abnormalities in cancer (Tripathi et al. 2012 (Tripathi et al. , 2013 Moestue et al. 2011; Bathen et al. 2010) . The metabolic profile of healthy and neoplastic breast has already been studied by HR-MAS NMR spectroscopy. (Sitter et al. 2002; Cheng et al. 1998) The main metabolic differences between healthy and neoplastic breast tissues are in choline containing compounds (ChoCC), taurine (Tau), glycine (Gly) and glucose (Glc) (Moestue et al. 2011; Bathen et al. 2010) .
Even though the feasibility of HR-MAS NMR has been proposed as a potential method for on-line analysis of resection margins during breast cancer surgery by different research groups (Bathen et al. 2013; Li et al. 2011; Kinross et al. 2011) , as far as we know only one case of real-time metabolic profiling of biopsy specimens during a surgical operation has been reported (Piotto et al. 2012 ). At present, spatial localization of spectrometers and instrument time constraints prevent the direct application of HR-MAS NMR analysis on tissue samples immediately after resection in most cases. Usually, samples are snap-frozen in liquid nitrogen and then stored to -80°C or at lower temperatures. A critical issue to be addressed in these kind of approach is the interaction with the surgical teams, which can vary from time to time, with considerable risks of collecting samples with different thermal histories or contamination. In our experience, the best way to collect samples is that a unit of the spectroscopy staff go personally into the operatory theatre with a Dewar containing liquid nitrogen. Nevertheless, this is not always possible for difficulties associated with changes of surgical teams, last minute scheduling of operations, interference in operating theatre protocols and organization. These considerations prompted us to undertake a study on tissue samples collected by Modena BioBank, which represent an efficient supply channel of tissue samples. The Modena BioBank collects and stores tissue samples and associated data for medical-scientific research and diagnostic purposes.
Nowadays breast cancer is still the most common malignant tumor diagnosed in adult female population worldwide (Ferlay et al. 2013 , http://globocan.iarc.fr). The areas of high risk are North America, Europe and Australia where 6 % of women develop invasive breast cancer before age 75 (Tavassoli and Devilee 2003) . In Italy, although the breast cancer incidence and its mortality declined for younger women, its incidence rate is still high. (Rossi et al. 2013; Quaglia et al. 2013) In the Province of Modena the incidence of breast cancer amount to 29.8 % of the overall solid tumors in female gender with an increasing trend in the period 2001-2011 (Federico et al. 2013) .
Here, we present a study on healthy and neoplastic breast samples collected by Modena BioBank in the period July 2011-April 2012 from 22 patients. It has two main goals: (i) to monitor the effect of freezing on the metabolic profile of tissues over time (12 months) and (ii) to verify if the metabolic information encoded in healthy and neoplastic tissues is preserved in the same period.
Healthy and neoplastic breast samples of Modena BioBank were analyzed through HR-MAS NMR 1, 6 and 12 months after collection.
Materials and methods

Samples collection
The study includes 22 adult female patients living in Modena and its hinterland, who underwent total mastectomy or quadrantectomy from July 2011 to April 2012 for previous cytological diagnosis of breast carcinoma. Tissue specimens were transported on ice from surgical room to the pathology department where they were immediately sampled. Three fresh samples of both neoplastic and macroscopically healthy appearing peritumoral breast tissue (2-3 cm from the tumor margins) were obtained from each patients and transferred immediately into a freezer at -80°C for storage. The mean time interval from surgical specimen resection to freezing of samples was about 30 min.
Histopathological features
The main clinical and histopathological features of the cases are provided in Table 1 . In particular the average age at diagnosis was 65 ± 16 years old (range 35-90). Tumors occurred in the right breast (15 cases) and in the left (7 cases) and included infiltrating ductal carcinoma (15 cases), infiltrating lobular carcinoma (5 cases), infiltrating mixed ductal-lobular carcinoma (1 case) and infiltrating ductal carcinoma with abundant extracellular mucin, ([50 % of the tumor component-mucinous carcinoma) (1 case) (Tavassoli and Devilee 2003) . The average tumor dimension was 2.3 cm (range 1-5 cm), and the tumor grading (Elston and Ellis 1991) was G2 (moderately differentiated) in 16 cases and G3 (poorly differentiated) in 6. Twelve tumors were in stage I and 10 in stage II (Sobin et al. 2009 ). Lymphovascular invasion was observed in five cases while perineural infiltration in two.
Ethical issue
All relevant ethical issues were identified and discussed with the local Ethical Committee who approved the Modena BioBank protocol for the collection of the specimens and the format of the written informed consent for the patients. All biological samples were anonymized prior to analysis. No further ethical approval was necessary to perform histological, immunohistochemical and other biochemical investigations.
HR-MAS NMR measurements
1 H HR-MAS NMR spectra were recorded with a Bruker Avance400 (Bruker BioSpin, Karlsruhe, Germany) spectrometer operating at a frequency of 400.13 MHz. The instrument was equipped with a 1 H, 13 C HR-MAS probe. Before HR-MAS examination, 20 lL of D 2 O were added to each sample to improve the homogeneity, the water suppression, and to add deuterium as a nucleus for the lock system. The sample was introduced in a MAS zirconia rotor (4 mm OD) maintained on ice, fitted with a 50 lL cylindrical insert to increase sample homogeneity, and then transferred into the probe cooled to 5°C. Total time for sample preparation prior to NMR analysis was only a few minutes.
Experiments were performed at a temperature of 5°C controlled by a Bruker cooling unit.
Samples were spun at 4 kHz and three different types of one-dimensional (1D) proton spectra were acquired by using the sequences implemented in the Bruker software: (i) a composite pulse sequence (zgcppr) (Bax 1985) with 2.5 s water presaturation during the relaxation delay, 8 kHz spectral width, 32k data points, 32 scans, (ii) a watersuppressed spin-echo Carr-Purcell-Meiboom-Gill (CPMG) sequence (cpmgpr) (Meiboom and Gill 1958 ) with 1.5 s water presaturation during the relaxation delay, 1 ms echo time (s) and 360 and 720 ms total spin-spin relaxation delay (2ns), 8 kHz spectral width, 32k data points, 128-256 scans.
Data analysis HR-MAS
1 H NMR CPMG data were processed by using MestReNova 8.1 (2012 Mestrelab Research S.L., Santiago de Compostela, Spain) software, by applying 1 Hz line broadening prior to Fourier transformation, manually phased and baseline corrected (third-order polynomial). The spectra are referenced to the chemical shift of choline at 3.206 ppm. Then they were binned (0.001 ppm), normalized (with respect to the total area in the range 4.20 and 2.95 ppm) and aligned in the region 4.70-2.95 ppm, obtaining 1,750 final data point sub-spectrum for each sample. The spectral intensities matrix was processed with MetaboAnalyst 2.0 (http://www.metaboanalyst.ca/Meta boAnalyst/faces/Home.jsp) (Xia et al. 2009 (Xia et al. , 2012b and Principal Component Analysis (PCA) and Partial Least Squares-Discriminant Analysis (PLS-DA) were run on the unscaled data. Data were filtered based on interquantile range and 1,049 variables were left for each sample.
One-way Analysis of Variance (ANOVA) was also run with MetaboAnalyst, using Fisher's Least Significant Difference method (Fisher's LSD), followed by post hoc analyses using Tukey's Honestly Significant Difference (Tukey's HSD).
Receiver Operating Characteristic Curve Explorer & Tester (ROCCET) (http://www.roccet.ca/ROCCET) (Xia et al. 2012a ) software was applied on selected integrals in order to build a classification model.
The healthy CPMG (720 ms, 2ns) dataset was formed by 56 spectra (15 spectra taken after 1 month, 21 after 6 months and 20 after 12 months). The neoplastic CPMG (720 ms, 2ns) dataset was formed by 54 spectra (15 spectra taken after 1 month, 20 after 6 months and 19 after 12 months). Some spectra are lacking due to temporary instrumental unavailability at the scheduled times.
3 Results and discussion
NMR spectra
Breast tissue (especially the healthy one, see below) is rich in fat, that gives rise to very huge signals in presaturated 1D 1 H NMR spectrum. An experiment more suitable than the basic ''pulse-and-acquire'' one to detect signals from small metabolites is the CPMG sequence, that reduces triglyceride resonances. This attenuation is more efficient for signals coming from bonded glycerol (TG gl ) and from methylenes a and b to carbonyl in fatty acid chains (TG a and TG b ) and it is a function of the total echo time employed in the experiment. Figure 1 compares the standard presaturated 1D 1 H NMR spectra (traces a and d), obtained from a macroscopically healthy (a) and from neoplastic (d) sample, with the CPMG spectra acquired with 360 (traces b and e) and 720 ms (traces c and f) total echo times. It appears that, if the main aim is to observe changes in metabolites signal during frozen storage, only a total 720 ms allows to better detect signals between 4.7 and 2.9 ppm especially in the healthy samples. It is to be stressed that, having the protons different transverse relaxation times (T 2 ), this long total echo time alters the relative signal intensities for the observed metabolites with respect to those that could be found within a standard presaturated 1D 1 H NMR spectrum in the absence of strong fat bands. Keeping this in mind, nothing prevents us to study how CPMG spectra of healthy or neoplastic samples, obtained at the same total echo time, change with time and to compare the spectra of healthy with those of neoplastic tissues.
3.2 Analysis of CPMG spectra 1, 6 and 12 months after surgery
The major changes clearly observed looking at the average CPMG spectra of frozen samples at -80°C for 1, 6 and 12 months (reported in Fig. S1 ) is the enhancement of the free choline (Cho) signal at 3.21 ppm, both in healthy and neoplastic samples, and the lowering of the phosphocholine (PC) signal at 3.22 ppm, in the case of the healthy ones. These findings are in accordance with Jordan et al.'s paper (Jordan et al. 2007 ): they found minimal changes in metabolites during a study on prostate tissues in evaluating the metabolites concentration after 3 years storage at -80°C. In our samples, the minimal alteration in ChoCC is consistent with their results. The increase of free Cho may be due to a small degradation of PC and glycerophosphocholine (GPC) during time, even if the mechanisms for the degradation of the phosphorylated Cho derivatives is not completely understood (Swanson et al. 2008) . Also Gly singlet (overlapped to a Myo signal) seems to slightly enhance in healthy samples, whereas a singlet at 3.34 ppm (labelled X, which could be methanol or trimethylamine N-oxide, but could not be unambiguously assigned in this study, for the signals of metabolites are not detected in HSQC spectra, due to the huge H, C correlations of TGs that causes dynamic range problems) seem to increase and then decrease with time in healthy tissue and to enhance in the neoplastic ones. Finally, a decrease of Tau is observed in tumoral samples. PCA was applied to the spectra set of healthy breast samples in order to see if some time-dependent clustering occurred and to better highlight metabolite variations. The first four PC account for 95.7 % of the total variance and allow us to infer information on the metabolites that can be responsible for the observed clustering. PC1, PC3, PC4 score plot, reported in Fig. 2a , shows that some trends with time should be present in our sets, at least as far as spectra acquired after 1 and 12 months are concerned, whereas the scores of the spectra acquired after 6 months appear to be more scattered. The loadings profile of PC1 (Fig. S2) follows very close the global spectrum and does not help in highlighting trends over time, as does PC2 (Fig. S2 ) that captures mainly the variance due to X. This signal is not reported by other authors (Bathen et al. 2013; Li et al. 2011) and it is probably due to the thermal history of the samples. If we cut out X and repeat PCA analysis, we observe a very similar clustering only in the PC1, PC2, PC3 scores plot (Fig. S3) . Inspection of the loadings of PC3 and PC4 (Fig. 2a) , seems to indicate that Cho, Cr, Myo, PC, X and Glc are the metabolites that vary with time in healthy samples.
In order to check which of these metabolites varies significantly among the three sets of spectra, one-way Analysis of Variance (ANOVA) and post hoc test was employed. Statistically significant differences (p \ 0.0001) were found only for Cho at 3.21 ppm and PC at 3.22 ppm, when 1 versus 12 and 6 versus 12 months classes are compared. In the case of PC, also 1 and 6 months classes were significantly different.
To confirm the trends observed on spectra, the signals of metabolites less overlapped, i.e. b-Glc (4.65 ppm), ascorbate (Asc 4.51 ppm), Lac (4.12 ppm), Myo (4.05 ppm), phosphoethanolamine (PE, 3.98 ppm), Tau (3.40 ppm), X (3.34 ppm), PC (3.22 ppm), Cho (3.21 ppm), ethanolamine (E, 3.13 ppm) and Cr (3.03 ppm) were integrated (Fig. 2b) . Gly was not integrated for it strongly overlaps to a signal of Myo at the magnetic field employed. One-way ANOVA and post hoc test of the integrated areas showed that PC is significantly different (-Log(p) [ 6) in the three classes, whereas Cho changes are significant (-Log(p) [ 6) only when 1 versus 12 months and 6 versus 12 months classes are compared.
Neoplastic breast
The same approach employed for healthy samples was applied to spectra of the neoplastic ones. In this case PCA shows a less defined trend with time (Figs. 3a, S4 ). The first three PCs account for 95.3 % of the total variance and the principal component that seems to better describe some time-trend is PC2, the loadings profile of which is reported, together with that of PC3, in Fig. 3a (the loading of PC1 follows very close the global spectrum and it is not shown).
The PC2 loadings profile seems to indicate that Cho, PC and Tau can be the metabolites varying more with time in neoplastic samples, whereas one-way ANOVA and post hoc test on spectra point to Cho as the only metabolite changing significantly in time, at least when comparing spectra acquired after 1 and 12 months and 6 and 12 months (p \ 0.0001).
Integrals of selected metabolites (Fig. 3b) were computed also for normalized spectra of neoplastic samples. One-way ANOVA and post hoc test of the integrated areas showed that Cho is significantly different (p \ 0.0002) when 1 and 12 months and 6 and 12 months classes are compared, whereas Tau (p \ 0.05) when the comparison is between 1 and 12 months classes.
On the whole, the changes over time of Cho and PC signals in frozen tissues represent not a trivial finding, since many studies base the distinction between neoplastic and healthy tissues or the assessment of tumor grade on the analysis of choline metabolites.
Comparison between healthy and neoplastic CPMG spectra
The second goal of this work was to verify if, for breast tissues obtained through the Modena BioBank protocol, the metabolic information related to healthy/neoplastic state remains encoded in CPMG spectra, despite the relatively high temperatures experienced by the samples collected through the BioBank before freezing (with respect to those snap-frozen in liquid nitrogen in the operating theater). All the spectra of the healthy class were compared to all those of the neoplastic one. The t test run on the metabolite region of the spectra of the two classes indicates that statistically significant differences (-Log(p) [ 5) are found, especially when Cho, PC, Tau, Myo, Lac, Asc, PE and Glc signals are concerned (Fig. S5) .
Applying the PCA approach it can be seen that neoplastic and healthy samples cluster, as is shown in Fig. 4a .
The first three PCs account for 91.7 % of the total variance, and another 1.8 % is captured by PC4 which is dominated by X signal (Fig. S6) . Neoplastic samples have PC2 values higher than those of the healthy ones, i.e. should have at least higher PC, Tau, Lac, PE, Cr and Asc signals and lower Myo, X and b-Glc.
PLS-DA was also run with Metaboanalyst, obtaining a good discrimination between the two classes (Fig. 4b) . The optimal number of components, three, was determined through 10-fold cross validation (Fig. S7) . To assess the significance of class discrimination, a permutation test was performed (Fig. S7) . In each permutation, a PLS-DA model was built between the data and the permuted class labels using the optimal number of components determined by cross validation for the model based on the original class assignment.
PLS-DA loadings profile is very close to that of PC2 in Fig. 4a . It indicates the enhancement of Lac, Tau, PE, PC, Cr and Asc, and to the decreasing of X, Glc and Myo in the neoplastic samples with respect to the healthy ones.
To verify these results of multivariate analysis, integrated areas of the previously selected signals where compared and a ROC analysis (Xia et al. 2012a ) was undertaken.
Analysis of integrals in healthy and neoplastic samples
PCA and PLS-DA point to some metabolites for the distinction of healthy and neoplastic classes, and the signals of these metabolites were integrated after normalization. When Glc, Asc, Lac, Myo, Tau, PC, Cho, E, PE and Cr integrals were compared (Fig. 5a) , it was observed that the differences between all the mean values of healthy and neoplastic distributions are significant at a p level\0.0003, except for Cr (p = 0.8) and E (p = 0.05).
ROC analysis of integrals of the same metabolites (Fig. 5b) confirmed that those more promising for a classification of breast tissue are PE, Lac, PC, Myo, Tau and Glc for which area under ROC curves (AUC) is above 0.8 (Xia et al. 2012a) . Also some metabolites combinations (Fig. 5c ) seem to be useful for a classification. They were built combining the metabolites with the highest AUC that enhance in neoplastic tissue (PE, Lac, PC and Tau) and in healthy tissue (Glc and Myo). We tried also ratios, that are self-normalized quantities and simplify the use of integrals.
The ROC results point to PE (-Log(p) = 16.1), Lac (-Log(p) = 13.1), and to some of their combinations with other metabolites as good indexes for the healthy/neoplastic classification. In particular, Lac ? Tau (-Log(p) = 26.3), Lac ? PE ? Tau (-Log(p) = 27.9), PE ? Tau (-Log(p) = 21.8), and the ratios PE ? Tau/ Glc ? Myo (-Log(p) = 10.4), Lac ? Tau/Glc ?
Myo (-Log(p) = 10.8), Lac ? PE ? Tau/Glc ? Myo (-Log(p) = 11.1) seem promising combinations of biomarkers. Moreover, the ratios are confined in very narrow intervals for healthy samples, whereas they are found in wider and fairly distinguished ranges for the neoplastic ones. All of these metabolites are reported to be involved in cancer metabolism. An increased consumption of glucose and high accumulated levels of lactate in tumor samples are consistent with the Warburg effect (Warburg 1956; Vander Heiden et al. 2009 ). Hypoxia, inadequate oxygen supply to the cells, is frequently found in solid malignant tumors and is characterized by enhanced formation of Lac produced by anaerobic glycolysis (Warburg 1956 ). Lower Glc combined with higher Lac levels in cancer patients indicate a difference in glycolytic activity between the two groups. High Lac levels have been shown to correlate with malignancy, increased risk of radiation resistance, metastasis, and reduced recurrence-free and overall survival in several types of cancers (Tripathi et al. 2012 (Tripathi et al. , 2013 Quennet et al. 2006; Brizel et al. 2001; Walenta et al. 2000; Cheng et al. 1998) .
The ChoCC are of high interest in cancer research and abnormal choline metabolism is frequently observed (Tripathi et al. 2012 (Tripathi et al. , 2013 Glunde et al. 2011) . Samples with high tumor cell content have higher levels of ChoCC compared to healthy samples, with PC being especially elevated in tumors. This reflects the increased proliferation rate in tumors, as Cho is an important constituent of cell membranes through the formation of phosphatidylcholine (PtdCho); PC and GPC are considered precursors and breakdown products of this activity (Ackerstaff et al. 2003; Esmaeili et al. 2014) . The abnormal PC and GPC levels in cancer have been linked to altered enzyme activity, in particular of choline kinase (ChoK) and several phospholipases (Glunde et al. 2011; Podo 1999) . In mammals, ChoK is encoded by two separate genes: ChoKA and ChoKB, catalyzing the phosphorylation of Cho to PC (Aoyama et al. 2004) . The activity of these enzymes depends on oncogenic signaling and microenvironmental parameters such as hypoxia (Jiang et al. 2012) . (1) samples. Red dot optimal cut-off levels (sensitivity, 1-specificity) and AUC ROC (95 % confidence interval) are also reported (Color figure online) BioBank healthy and neoplastic breast tissues 495
Also PE is precursor of the cell membrane phosphatidylethanolamine (PtdEtn), and it is formed by degradation of PtdEtn by phospholipase C. PE has been linked to cancer (Podo 1999) and a recent study on breast cancer has reported that PE induces apoptosis directly through the mitochondrial pathway, leading to a disruption of mitochondrial membrane potential followed by a release of Cytochrome c from mitochondria. Furthermore, the arrest at the G1 phase of the cell cycle is in accordance with the observed decrease in Cyclin D1 expression, strongly supporting that PE has a dual mechanism of action i.e. it induces apoptosis and blocks the cell cycle in MCF-7 tumor cells (Ferreira et al. 2013) . Hence, PE has been proposed as anticancer compound.
Elevated level of Tau, osmolite involved in many essential biological functions such as antioxidation, membrane stabilization, and cell shrinkage during apoptosis, should indicate that it is implicated in breast cancer metabolism (Choi et al. 2012 ). Choi study showed higher concentrations of Tau and Gly being associated with progesterone receptor (PR) negative/receptor for human epidermal growth factor (HER2) positive cancers and with a poor prognosis.
As for Gly, we observed only a slight increase in neoplastic samples with respect to the healthy ones whereas in previous reports it has been found to contribute to characterization of breast cancer tissues (Jain et al. 2012; Cao et al. 2012; Sitter et al. 2006) . Jain et al. (2012) identified the correlation of Gly with rapid cancer cell proliferation, and that a higher expression of the mitochondrial Gly biosynthesis pathway is associated with higher mortality in breast cancer patients. High levels of Gly and Lac in breast cancer tissues might potentially be associated with high grade malignancy and tumor aggressiveness probably caused by altered glycolysis (Peeling and Sutherland 1992; Cao et al. 2012) . Sitter et al. (2006) reported that Gly concentrations were significantly higher in breast cancers larger than 2 cm compared to those of smaller ones. Hence, since only 8 out of 22 samples here studied were larger than 2 cm, we believe that the slight increase of Gly in the neoplastic samples could be related to the small tumor dimensions and to the early diagnosis.
Conclusions
The samples collected through Modena BioBank have a thermal history different with respect to that of samples snap frozen in liquid nitrogen immediately after surgery, for the time elapsed between surgery and freezing is around 30 min. During this time, only some metabolic changes have been observed for rat brain cortex (Opstad et al. 2008) or liver (Cacciatore et al. 2013 ). In particular, significant changes have been observed for Lac, alanine (Ala), c-aminobutyric acid and Glc in the case of rat brain, and for aspartate and Gly in human liver in the first 30 min after sample excision. When our spectra are compared to those reported by Bathen et al. (2013) and Li et al. (2011) who immediately froze tissues in liquid nitrogen after excision or biopsy, we can hardly infer clear differences, apart from the presence of the signal at 3.34 ppm.
The changes observed during freezing affects significantly PC and Cho, and seem also to influence other metabolites (Figs. 2c, 3c) , even though at a lesser extent. These findings suggest that care should be used when employing only ChoCC signals for the distinction between neoplastic and healthy tissues or the assessment of tumor grade.
Despite half an hour on ice before freezing, HR-MAS NMR spectra of neoplastic samples remain sufficiently different from those of the healthy one, and they cluster in two groups when PCA is run on CPMG spectra. The differences between healthy and neoplastic tissues, as derived from PCA and PLS-DA, correspond to the enhancement of Lac, Tau, PC, PE, Cr, Asc and a slight enhancement of Gly, and to the lowering of X, Glc and Myo in the neoplastic samples with respect to the healthy ones. The analysis of integrals shows that only changes in Glc, Asc, Lac, Myo, Tau, PC, PE and Cho are statistically significant at a p \ 0.0003. These results are very close to that observed and already discussed by Bathen et al., with few differences probably due to the spectrometer field (we can hardly resolve Gly from Myo) and to the longer total echo time employed by us.
The use of ROC curves helps in the discrimination between healthy and neoplastic breast tissue. Good biomarkers for the classification seem to be PE, Lac and combinations of Lac, PE, Tau, Myo and Glc. Among these, some ratios, such as Lac ? PE ? Tau/Glc ? Myo, are found in very narrow intervals for healthy samples, well distinguished from the neoplastic ones.
